Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.
Paul MR, Pan TC, Pant DK, Shih NN, Chen Y, Harvey KL, Solomon A, Lieberman D, Morrissette JJ, Soucier-Ernst D, Goodman NG, Stavropoulos SW, Maxwell KN, Clark C, Belka GK, Feldman M, DeMichele A, Chodosh LA.
Paul MR, et al. Among authors: stavropoulos sw.
J Clin Invest. 2020 Aug 3;130(8):4252-4265. doi: 10.1172/JCI129941.
J Clin Invest. 2020.
PMID: 32657779
Free PMC article.